Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Stanssens

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Protocols in Molecular Biology|February 12, 2008
AFLP-based transcript profilingPieter Vos, Patrick Stanssens
Biotechniques|June 27, 2002
A strategy for the rapid discovery of disease markers using the MassARRAY systemCharles P Rodi, Brigitte Darnhofer-Patel, Patrick Stanssens, et al.
Microbial Cell Factories|June 9, 2016
Pichia pastoris Mut(S) strains are prone to misincorporation of O-methyl-L-homoserine at methionine residues when methanol is used as the sole carbon sourcePeter Schotte, Isabelle Dewerte, Manu De Groeve, et al.
The Journal of Molecular Diagnostics : JMD|November 1, 2005
Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancerMarjo van Puijenbroek, Jan Willem F Dierssen, Patrick Stanssens, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2005
Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometryMathias Ehrich, Matthew R Nelson, Patrick Stanssens, et al.
Genome Research|January 7, 2004
High-throughput MALDI-TOF discovery of genomic sequence polymorphismsPatrick Stanssens, Marc Zabeau, Geert Meersseman, et al.
Blood|May 18, 2011
Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugsHans Ulrichts, Karen Silence, Anne Schoolmeester, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Protocols in Molecular Biology|February 12, 2008
AFLP-based transcript profilingPieter Vos, Patrick Stanssens
Biotechniques|June 27, 2002
A strategy for the rapid discovery of disease markers using the MassARRAY systemCharles P Rodi, Brigitte Darnhofer-Patel, Patrick Stanssens, et al.
Microbial Cell Factories|June 9, 2016
Pichia pastoris Mut(S) strains are prone to misincorporation of O-methyl-L-homoserine at methionine residues when methanol is used as the sole carbon sourcePeter Schotte, Isabelle Dewerte, Manu De Groeve, et al.
The Journal of Molecular Diagnostics : JMD|November 1, 2005
Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancerMarjo van Puijenbroek, Jan Willem F Dierssen, Patrick Stanssens, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2005
Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometryMathias Ehrich, Matthew R Nelson, Patrick Stanssens, et al.
Genome Research|January 7, 2004
High-throughput MALDI-TOF discovery of genomic sequence polymorphismsPatrick Stanssens, Marc Zabeau, Geert Meersseman, et al.
Blood|May 18, 2011
Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugsHans Ulrichts, Karen Silence, Anne Schoolmeester, et al.
Pageof 1